v3.25.3
Segment Reporting
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Reporting

Note 9 – Segment Reporting

 

The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, currently located in a single geographic location, the United States. The accounting policies of the segment are the same as those described in the summary of significant accounting policies. Since the Company operates in a single segment, the measure of segment total assets and loss from operations is the same as that reported on the accompanying balance sheets as total assets, and the accompanying statement of operations as loss from operations, respective.

 

 

The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The Company’s CODM reviews and evaluates the total consolidated net loss for purposes of assessing performance, making operating decisions, allocating resources, and planning and forecasting for future periods. In addition to the significant expense categories included within the total net loss presented on the Company’s Statements of Operations, the following table sets forth significant segment expenses:

 

   2025   2024   2025   2024 
   For the Three Months Ended
September 30,		   For the Nine Months Ended
September 30,		 
   2025   2024   2025   2024 
                 
Patient revenue, net  $21,223   $56,300   $22,723   $72,050 
Cost of revenues   123,877    122,077    329,392    194,079 
Gross profit   (102,654)   (65,777)   (306,669)   (122,029)
                     
Operating expenses:                    
                     
Employee expense   1,153,316    564,719    3,100,341    1,146,128 
Professional fees   421,462    1,195,633    1,856,741    2,106,168 
Occupancy   74,680    56,470    212,235    92,804 
Insurance   69,527    72,094    209,124    239,342 

Loss on impairment of property and equipment

   748,101    -    748,101    - 
Other   31,859    41,398    329,402    100,194 
Total operating expenses   2,498,945    1,930,314    6,455,944    3,684,636 
                     
Operating loss   (2,601,599)   (1,996,091)   (6,762,613)   (3,806,665)
                     
Other income (expense):                    
Interest income   39    1,453    224    2,448 
Interest expense   (466,599)   (106,636)   (626,217)   (159,062)
Total other income (expenses)   (466,560)   (105,183)   (625,993)   (156,614)
                     
Income (loss) from continuing operations, net of income taxes  $(3,068,159)  $(2,101,274)  $(7,388,606)  $(3,963,279)